ArticleSurgery today2014

Impact of second-line and later cetuximab-containing therapy and KRAS genotypes in patients with metastatic colorectal cancer: a multicenter study in Japan.

Hiroshi Saeki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.